Salmex 50+100 mikrog/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

salmex 50+100 mikrog/dosis inhalationspulver, afdelt

nordic prime aps - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+100 mikrog/dosis

Salmex 50+250 mikrog/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

salmex 50+250 mikrog/dosis inhalationspulver, afdelt

nordic prime aps - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+250 mikrog/dosis

Salmex 50+500 mikrog/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

salmex 50+500 mikrog/dosis inhalationspulver, afdelt

nordic prime aps - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+500 mikrog/dosis

Asthmex 50+250 mikrog/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

asthmex 50+250 mikrog/dosis inhalationspulver, afdelt

orifarm a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+250 mikrog/dosis

Asthmex 50+500 mikrog/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

asthmex 50+500 mikrog/dosis inhalationspulver, afdelt

orifarm a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+500 mikrog/dosis

BroPair Spiromax Evrópusambandið - danska - EMA (European Medicines Agency)

bropair spiromax

teva b.v. - salmeterol xinafoate, fluticasonpropionat - astma - medicin for obstruktiv sygdomme, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seffalair Spiromax Evrópusambandið - danska - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - medicin for obstruktiv sygdomme, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Serefarm 50+100 mikrogram/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

serefarm 50+100 mikrogram/dosis inhalationspulver, afdelt

orifarm generics a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+100 mikrogram/dosis

Serefarm 50+250 mikrogram/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

serefarm 50+250 mikrogram/dosis inhalationspulver, afdelt

orifarm generics a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+250 mikrogram/dosis

Serefarm 50+500 mikrogram/dosis inhalationspulver, afdelt Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

serefarm 50+500 mikrogram/dosis inhalationspulver, afdelt

orifarm generics a/s - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+500 mikrogram/dosis